Enterprise Solutions Webinars

  1. BE Biosol Capabilities Update August 2026: CPHI Special Edition 9/2/2026

    BE BioSol is the biologics CDMO business of Biological E. Limited, combining more than 70 years of biopharmaceutical manufacturing experience with a growing, integrated development and manufacturing platform for global biopharma partners.

  2. Faster Paths To Biosimilar Equivalence: Turning Guidance Into An Advantage 9/1/2026

    Evolving biosimilar guidance creates opportunities to reduce comparative clinical requirements through strong analytical evidence, risk-based justification, structure-function knowledge, and more.

  3. New Facility, New Filling Line: A Sterile Fill-Finish CDMO 8/27/2026

    A new sterile fill-finish facility and advanced filling line expand capacity, flexibility, and quality oversight, helping accelerate the path from clinical development to commercial supply.

  4. Recipharm 8/24/2026

    Our development approach is designed to help you move faster from early formulation work to manufacturing readiness and transform complex formulation challenges into more predictable development outcomes.

  5. Quality With Purpose: From Manufacturing Excellence To Patient Impact 8/19/2026

    When quality and purpose align, pharmaceutical teams can overcome challenges, accelerate innovation, and bring safe, effective therapies to patients worldwide.

  6. New Promises, New Pressures, No Problem - Service Care Packages 8/19/2026

    Tighter production schedules leave little room for equipment disruption. Get support that can strengthen maintenance strategies, reduce operational risk, and help internal teams sustain performance.

  7. Lonza Capabilities Update August 2026: Cell Line Development 8/18/2026

    Omeco Barrett, Principal Scientist, Global Process Development, highlights Lonza’s latest development in cell line expression technology and cell line development (CLD).

  8. From The Army Commander To The CDMO Corner Office 8/15/2026

    A discussion on what drives CDMO success, from operational discipline and leadership to tackling complex manufacturing challenges and industry trends.

  9. When Unexpected Particles Threaten Your Biologic 8/13/2026

    Particle contamination risks biologic safety. Advanced tools like Raman and SEM-EDS identify root causes fast to support robust, regulator-ready strategies that protect product quality.

  10. What Makes ADC Tech Transfers So Difficult? 8/11/2026

    In this opening segment from the Bioprocess Online Live event “Ensuring Successful Technology Transfer In ADC Development,” panelists Sourav Kundu, Ph.D., and Will Olughu, Ph.D., explain how ADC constructs complicate process and knowledge transfers compared to traditional biologics.